Publicacións (8) Publicacións de Patricia Jauregui Jiménez

2023

  1. Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

    Frontiers in Immunology, Vol. 14

2022

  1. Correction to: Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice (Probiotics and Antimicrobial Proteins, (2022), 14, 3, (407-414), 10.1007/s12602-022-09916-6)

    Probiotics and Antimicrobial Proteins

  2. Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice

    Probiotics and Antimicrobial Proteins, Vol. 14, Núm. 3, pp. 407-414

2021

  1. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells

    Cell Death and Disease, Vol. 12, Núm. 4

  2. CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

    Nature Communications, Vol. 12, Núm. 1

2020

  1. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer

    International Journal of Cancer, Vol. 147, Núm. 4, pp. 1163-1179

  2. Tumor-associated fibroblasts promote HER2-targeted therapy resistance through FGFR2 activation

    Clinical Cancer Research, Vol. 26, Núm. 6, pp. 1432-1448

2018

  1. Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

    Cancer Letters, Vol. 424, pp. 70-83